In the world of medical devices, holding on to proprietary technology often means going to the trenches. The industry's top companies sue one another for patent infringement, hoping to stymie their competition and win damages that pad their bottom line. Sometimes, battles are easily won without extensive legal proceedings. But in most cases, the courtroom drama spans countless hours as devicemakers appeal to obtain a favorable verdict.
This year is no exception to the rule, as med tech giants such as Johnson & Johnson, Medtronic and Boston Scientific faced a slew of patent battles, some of which have been years in the making. J&J's Ethicon unit warded off patent-infringement accusations from Irish device giant Covidien, fighting hard to keep its ultrasonic surgical product on the market. The device giant also scored a temporary win when Stryker dismissed its DePuy subsidiary from a patent-infringement suit over hip-implant technology.
Researchers hope that a new implantable device that encapsulates and nurtures pancreatic beta cells will provide sufficient insulin to Type 1 diabetes patients. The first patient in an 8-patient clinical trial has already been implanted with the device, the βAir Bio-Artificial Pancreas from Israeli startup Beta-O2.
The startup expects that the device will address three primary obstacles for a bio-artificial pancreas implant: avoiding rejection without a lifetime of immunosuppressive drugs, providing sufficient oxygen to the pancreatic cells to keep them functioning well and offering sufficient quantities of insulin to the patient.
We've picked the best and the brightest in all corners of the med tech industry including major companies, startups, venture capital, industry advocates and academics. We've chosen women who represent some of the major shifts and trends within the industry such as the ever-growing consumer orientation of healthcare, the advent of cheaper, easier personalized diagnostics, the use of diagnostics to inform preventative healthcare decisions and the increasing integration of wireless technology into medical devices.
POPULAR COMMENT THREADS
C.R. Bard provided more clarity around the launch strategy of the first FDA approved drug-coated balloon, the Lutonix 035 Drug Coated Balloon Catheter, during its third quarter earnings call today. Read more >>
Physical therapy to help stroke patients regain hand motor function after a stroke is so highly repetitive that patients often struggle through it. Irvine,CA-based startup Flint Rehabilitation Devices has launched a device that could make that process more effective and less excruciating.
C.R. Bard provided more clarity around the launch strategy of the first FDA approved drug-coated balloon, the Lutonix 035 Drug Coated Balloon Catheter, during its third quarter earnings call today.
Startup Gamma Medica is aiming to improve the odds and lower the cost of effective imaging of dense breast tissue with its molecular breast imaging tool. Now, it's gained a cash infusion of $11.5 million to aid in its commercialization efforts.
Johnson & Johnson is facing grave allegations that the company, in an effort to preserve billions in profit, ignored overwhelming evidence that its Pinnacle hip implants were highly dangerous.
Expect medical device companies to feel the squeeze from the advent of reference pricing, whereby patients must bear procedures' expenses that exceed a predetermined threshold.
From Our Sister Sites
In this week's EuroBiotech Report, Google revealed further details of its $100 million (€79 million) European venture capital unit, which is hunting for biotechs and startups in other sectors from its digs in London. And more.
As concern mounts over the deadly Ebola epidemic, French scientists are developing a diagnostic tool that works similar to a home pregnancy test and can quickly identify the virus through a tiny fluid sample.